{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:46:07Z","timestamp":1782715567566,"version":"3.54.5"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science and Technology Council, Taiwan","award":["NSTC 110-2320-B-182-003-MY3"],"award-info":[{"award-number":["NSTC 110-2320-B-182-003-MY3"]}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC 110-2320-B-182-003-MY3"],"award-info":[{"award-number":["NSTC 110-2320-B-182-003-MY3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11064-026-04762-2","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:47:46Z","timestamp":1779263266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Loss-of-Function (G603R) Lrp10 Fails to Downregulate mRNA of Pathologic \u03b1-Synuclein and Causes Neurodegeneration of Substantia Nigra Dopaminergic Cells in Parkinson\u2019s Disease Knockin Mice"],"prefix":"10.1007","volume":"51","author":[{"given":"Hung-Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu-Hsueh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Shia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Ju","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Rung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"4762_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304","journal-title":"Lancet"},{"key":"4762_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","volume":"25","author":"R Coukos","year":"2024","unstructured":"Coukos R, Krainc D (2024) Key genes and convergent pathogenic mechanisms in Parkinson disease. Nat Rev Neurosci 25:393\u2013413","journal-title":"Nat Rev Neurosci"},{"key":"4762_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1474-4422(18)30179-0","volume":"17","author":"M Quadri","year":"2018","unstructured":"Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E et al (2018) LRP10 genetic variants in familial Parkinson\u2019s disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study. Lancet Neurol 17:597\u2013608","journal-title":"Lancet Neurol"},{"key":"4762_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.parkreldis.2019.05.037","volume":"65","author":"LJM Vergouw","year":"2019","unstructured":"Vergouw LJM, Ruitenberg A, Wong TH, Melhem S, Breedveld GJ, Criscuolo C et al (2019) LRP10 variants in Parkinson\u2019s disease and dementia with Lewy bodies in the South-West of the Netherlands. Parkinsonism Relat Disord 65:243\u2013247","journal-title":"Parkinsonism Relat Disord"},{"key":"4762_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/mds.27693","volume":"34","author":"Y Chen","year":"2019","unstructured":"Chen Y, Cen Z, Zheng X, Pan Q, Chen X, Zhu L et al (2019) LRP10 in autosomal-dominant Parkinson\u2019s disease. Mov Disord 34:912\u2013916","journal-title":"Mov Disord"},{"key":"4762_CR6","doi-asserted-by":"publisher","first-page":"99.e1","DOI":"10.1016\/j.neurobiolaging.2020.08.015","volume":"99","author":"CY Li","year":"2021","unstructured":"Li CY, Chen YP, Ou RW, Gu XJ, Wei QQ, Cao B et al (2021) Mutation analysis of LRP10 in a large Chinese familial Parkinson disease cohort. Neurobiol Aging 99:99.e1\u201399.e9.","journal-title":"Neurobiol Aging"},{"key":"4762_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.parkreldis.2021.06.014","volume":"89","author":"A Manini","year":"2021","unstructured":"Manini A, Straniero L, Monfrini E, Percetti M, Vizziello M, Franco G et al (2021) Screening of LRP10 mutations in Parkinson\u2019s disease patients from Italy. Parkinsonism Relat Disord 89:17\u201321","journal-title":"Parkinsonism Relat Disord"},{"key":"4762_CR8","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s12035-020-02186-9","volume":"58","author":"QZ Zhao","year":"2021","unstructured":"Zhao QZ, Ning P, Yang X, Shi C, Xu Y et al (2021) LRP10 mutations may correlate with sporadic Parkinson\u2019s disease in China. Mol Neurobiol 58:1212\u20131216","journal-title":"Mol Neurobiol"},{"key":"4762_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/neup.12812","volume":"42","author":"CJ Choong","year":"2022","unstructured":"Choong CJ, Mochizuki H (2022) Neuropathology of \u03b1-synuclein in Parkinson\u2019s disease. Neuropathology 42:93\u2013103","journal-title":"Neuropathology"},{"key":"4762_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00401-024-02781-3","volume":"148","author":"RK Leak","year":"2024","unstructured":"Leak RK, Clark RN, Abbas M, Xu F, Brodsky JL, Chen J et al (2024) Current insights and assumptions on \u03b1-synuclein in Lewy body disease. Acta Neuropathol 148:18","journal-title":"Acta Neuropathol"},{"key":"4762_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JPD-240207","volume":"14","author":"A Bj\u00f6rklund","year":"2024","unstructured":"Bj\u00f6rklund A, Mattsson B (2024) The AAV-\u03b1-synuclein model of Parkinson\u2019s disease: An update. J Parkinsons Dis 14:1077\u20131094","journal-title":"J Parkinsons Dis"},{"key":"4762_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10048-016-0478-0","volume":"17","author":"L Tagliafierro","year":"2016","unstructured":"Tagliafierro L, Chiba-Falek O (2016) Up-regulation of SNCA gene expression: implications to synucleinopathies. Neurogenetics 17:145\u2013157","journal-title":"Neurogenetics"},{"key":"4762_CR13","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/nar\/gkn084","volume":"36","author":"J Grundemann","year":"2008","unstructured":"Grundemann J, Schlaudraff F, Haeckel O, Liss B (2008) Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson\u2019s disease. Nucleic Acids Res 36:e38","journal-title":"Nucleic Acids Res"},{"key":"4762_CR14","doi-asserted-by":"publisher","first-page":"e13124","DOI":"10.1111\/bpa.13124","volume":"33","author":"L Fan","year":"2023","unstructured":"Fan L, Zhang S, Li X, Hu Z, Yang J, Zhang S et al (2023) CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson\u2019s disease. Brain Pathol 33:e13124","journal-title":"Brain Pathol"},{"key":"4762_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/hmg\/ddy003","volume":"27","author":"S Yoshida","year":"2018","unstructured":"Yoshida S, Hasegawa T, Suzuki M, Sugeno N, Kobayashi J, Ueyama M et al (2018) Parkinson\u2019s disease-linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking. Hum Mol Genet 27:823\u2013836","journal-title":"Hum Mol Genet"},{"key":"4762_CR16","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","volume":"36","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA, Abdelmotilib H, Liu Z, Stoyka L, Daher JPL, Milnerwood AJ et al (2016) G2019S-LRRK2 expression augments \u03b1-synuclein sequestration into inclusions in neurons. J Neurosci 36:7415\u20137427","journal-title":"J Neurosci"},{"key":"4762_CR17","first-page":"2959","volume":"25","author":"TL da Fonseca","year":"2016","unstructured":"da Fonseca TL, Pinho R, Outeiro TF (2016) A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death. Hum Mol Genet 25:2959\u20132971","journal-title":"Hum Mol Genet"},{"key":"4762_CR18","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41467-023-37815-z","volume":"14","author":"T Fujii","year":"2023","unstructured":"Fujii T, Nagamori S, Wiriyasermkul P, Zheng S, Yago A, Shimizu T et al (2023) Parkinson\u2019s disease-associated ATP13A2\/PARK9 functions as a lysosomal H+,K+-ATPase. Nat Commun 14:2174","journal-title":"Nat Commun"},{"key":"4762_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/cells13040296","volume":"13","author":"LD Skou","year":"2024","unstructured":"Skou LD, Johansen SK, Okarmus J, Meyer M (2024) Pathogenesis of DJ-1\/PARK7-mediated Parkinson\u2019s disease. Cells 13:296","journal-title":"Cells"},{"key":"4762_CR20","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.3390\/ijms25126711","volume":"25","author":"CC Chiu","year":"2024","unstructured":"Chiu CC, Chen YL, Weng YH, Liu SY, Li AHL et al (2024) Downregulation of protease cathepsin D and upregulation of pathologic \u03b1-synuclein mediate paucity of DNAJC6-induced degeneration of dopaminergic neurons. Int J Mol Sci 25:6711","journal-title":"Int J Mol Sci"},{"key":"4762_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.expneurol.2008.04.004","volume":"212","author":"HH Hoepken","year":"2008","unstructured":"Hoepken HH, Gispert S, Azizov M, Klinkenberg M, Ricciardi F, Kurz A et al (2008) Parkinson patient fibroblasts show increased alpha-synuclein expression. Exp Neurol 212:307\u2013313","journal-title":"Exp Neurol"},{"key":"4762_CR22","doi-asserted-by":"publisher","first-page":"123789","DOI":"10.1016\/j.lfs.2025.123789","volume":"337","author":"CC Chiu","year":"2025","unstructured":"Chiu CC, Weng YH, Yeh TH, Chen WS, Liu SY, Chiu TJ et al (2025) Absence of Rab39b-induced macroautophagy impairment increases neurotoxic\u03b1-synuclein and causes degeneration of substantia nigra dopaminergic neurons in mouse model of X-linked Parkinson\u2019s disease. Life Sci 337:123789","journal-title":"Life Sci"},{"key":"4762_CR23","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.3390\/ijms25179197","volume":"25","author":"D Krawczuk","year":"2024","unstructured":"Krawczuk D, Groblewska M, Mroczko J, Winkel I, Mroczko B (2024) The role of \u03b1-synuclein in etiology of neurodegenerative diseases. Int J Mol Sci 25:9197","journal-title":"Int J Mol Sci"},{"key":"4762_CR24","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1093\/hmg\/ddx331","volume":"26","author":"SM Heman-Ackah","year":"2017","unstructured":"Heman-Ackah SM, Manzano R, Hoozemans JJM, Scheper W, Flynn R, Haerty W et al (2017) Alpha-synuclein induces the unfolded protein response in Parkinson\u2019s disease SNCA triplication iPSC-derived neurons. Hum Mol Genet 26:4441\u20134450","journal-title":"Hum Mol Genet"},{"key":"4762_CR25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fnins.2019.00560","volume":"13","author":"E Colla","year":"2019","unstructured":"Colla E (2019) Linking the endoplasmic reticulum to Parkinson\u2019s disease and alpha-synucleinopathy. Front Neurosci 13:560","journal-title":"Front Neurosci"},{"key":"4762_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.toxlet.2020.01.019","volume":"324","author":"Z Mou","year":"2020","unstructured":"Mou Z, Yuan YH, Zhang Z, Song LK, Chen NH (2020) Endoplasmic reticulum stress, an important factor in the development of Parkinson\u2019s disease. Toxicol Lett 324:20\u201329","journal-title":"Toxicol Lett"},{"key":"4762_CR27","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s10753-024-02156-6","volume":"48","author":"H Zeng","year":"2025","unstructured":"Zeng H, Liu Y, Liu X, Li J, Lu L, Xue C, Wu X, Zhang X, Zheng Z, Lu G (2025) Interplay of \u03b1-synuclein oligomers and endoplasmic reticulum stress in Parkinson\u2019s disease: Insights into cellular dysfunctions. Inflammation 48:1590\u20131606","journal-title":"Inflammation"},{"key":"4762_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ (2020) Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 21:421\u2013436","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4762_CR29","doi-asserted-by":"publisher","first-page":"15186","DOI":"10.3390\/ijms232315186","volume":"23","author":"A Merighi","year":"2022","unstructured":"Merighi A, Lossi L (2022) Endoplasmic reticulum stress signaling and neuronal cell death. Int J Mol Sci 23:15186","journal-title":"Int J Mol Sci"},{"key":"4762_CR30","doi-asserted-by":"publisher","first-page":"e2221929120","DOI":"10.1073\/pnas.2221929120","volume":"120","author":"DY Kim","year":"2023","unstructured":"Kim DY, Shin JY, Lee JE, Kim HN, Chung SJ et al (2023) A selective ER-phagy exerts neuroprotective effects via modulation of \u03b1-synuclein clearance in parkinsonian models. Proc Natl Acad Sci USA 120:e2221929120","journal-title":"Proc Natl Acad Sci USA"},{"key":"4762_CR31","doi-asserted-by":"publisher","first-page":"e12999","DOI":"10.1111\/nan.12999","volume":"50","author":"D Hrabos","year":"2024","unstructured":"Hrabos D, Poggiolini I, Civitelli L, Galli E, Esapa C, Saarma M et al (2024) Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha-synuclein levels in Lewy body disease. Neuropathol Appl Neurobiol 50:e12999","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"Suppl 1","key":"4762_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/jnc.13696","volume":"139","author":"D Toulorge","year":"2016","unstructured":"Toulorge D, Schapira AHV, Hajj R (2016) Molecular changes in the postmortem parkinsonian brain. J Neurochem 139(Suppl 1):27\u201358","journal-title":"J Neurochem"},{"key":"4762_CR33","doi-asserted-by":"publisher","first-page":"17027","DOI":"10.3390\/ijms242317027","volume":"24","author":"CJ Choong","year":"2023","unstructured":"Choong CJ, Mochizuki H (2023) Involvement of mitochondria in Parkinson\u2019s disease. Int J Mol Sci 24:17027","journal-title":"Int J Mol Sci"},{"key":"4762_CR34","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","volume":"48","author":"SM Vastegani","year":"2023","unstructured":"Vastegani SM, Nasrolahi A, Ghaderi S, Belali R, Rashno M, Farzaneh M et al (2023) Mitochondrial dysfunction and Parkinson\u2019s disease: pathogenesis and therapeutic strategies. Neurochem Res 48:2285\u20132308","journal-title":"Neurochem Res"},{"key":"4762_CR35","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1007\/s12035-024-04526-5","volume":"62","author":"MC Epifane-de-Assun\u00e7\u00e3o","year":"2025","unstructured":"Epifane-de-Assun\u00e7\u00e3o MC, Bispo AG, Ribeiro-Dos-Santos \u00c2, Cavalcante GC (2025) Molecular alterations in core subunits of mitochondrial complex I and their relation to Parkinson\u2019s disease. Mol Neurobiol 62:6968\u20136982","journal-title":"Mol Neurobiol"},{"key":"4762_CR36","doi-asserted-by":"publisher","first-page":"e00292","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B (2024) Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics 21:e00292","journal-title":"Neurotherapeutics"},{"key":"4762_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40478-019-0696-4","volume":"7","author":"X Wang","year":"2019","unstructured":"Wang X, Becker K, Levine N, Zhang M, Lieberman AP, Moore DJ et al (2019) Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun 7:41","journal-title":"Acta Neuropathol Commun"},{"key":"4762_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41531-024-00733-y","volume":"10","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ruan L, Wang H, Zhu J, Li T, Sun G et al (2024) Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity. NPJ Parkinsons Dis 10:120","journal-title":"NPJ Parkinsons Dis"},{"key":"4762_CR39","doi-asserted-by":"publisher","first-page":"167992","DOI":"10.1016\/j.jmb.2023.167992","volume":"435","author":"T Sohrabi","year":"2023","unstructured":"Sohrabi T, Mirzaei-Behbahani B, Zadali R, Pirhaghi M, Morozova-Roche LA, Meratan AA (2023) Common mechanisms underlying \u03b1-synuclein-induced mitochondrial dysfunction in Parkinson\u2019s disease. J Mol Biol 435:167992","journal-title":"J Mol Biol"},{"key":"4762_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13024-024-00756-2","volume":"19","author":"FF Geibl","year":"2024","unstructured":"Geibl FF, Henrich MT, Xie Z, Zampese E, Ueda J, Tkatch T et al (2024) \u03b1-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease. Mol Neurodegener 19:69","journal-title":"Mol Neurodegener"},{"key":"4762_CR41","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.4103\/1673-5374.385845","volume":"19","author":"T Han","year":"2024","unstructured":"Han T, Xu Y, Sun L, Hashimoto M, Wei J (2024) Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases. Neural Regen Res 19:1241\u20131248","journal-title":"Neural Regen Res"},{"key":"4762_CR42","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G (2024) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987","journal-title":"Front Aging Neurosci"},{"key":"4762_CR43","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S et al (2024) The immune system in Parkinson\u2019s disease: what we know so far. Brain 147:3306\u20133324","journal-title":"Brain"},{"key":"4762_CR44","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.3390\/ijms22158338","volume":"22","author":"A Jan","year":"2021","unstructured":"Jan A, Gon\u00e7alves NP, Vaegter CB, Jensen PH, Ferreira N (2021) The prion-like spreading of alpha-synuclein in Parkinson\u2019s disease: update on models and hypotheses. Int J Mol Sci 22:8338","journal-title":"Int J Mol Sci"},{"key":"4762_CR45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tins.2024.05.004","volume":"47","author":"AL Woerman","year":"2024","unstructured":"Woerman AL, Bartz JC (2024) Effect of host and strain factors on \u03b1-synuclein prion pathogenesis. Trends Neurosci 47:538\u2013550","journal-title":"Trends Neurosci"},{"key":"4762_CR46","doi-asserted-by":"publisher","first-page":"719807","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L et al (2021) Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease. Front Immunol 12:719807","journal-title":"Front Immunol"},{"key":"4762_CR47","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1007\/s00415-022-11491-3","volume":"270","author":"L Soraci","year":"2023","unstructured":"Soraci L, Gambuzza ME, Biscetti L, Lagan\u00e0 P, Lo Russo C, Buda A et al (2023) Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson\u2019s disease: mechanisms and therapeutic implications. J Neurol 270:1346\u20131360","journal-title":"J Neurol"},{"key":"4762_CR48","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","volume":"46","author":"J Singh","year":"2023","unstructured":"Singh J, Habean ML, Panicker N (2023) Inflammasome assembly in neurodegenerative diseases. Trends Neurosci 46:814\u2013831","journal-title":"Trends Neurosci"},{"key":"4762_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13578-024-01256-y","volume":"14","author":"L Zhang","year":"2024","unstructured":"Zhang L, Tang Y, Huang P, Luo S, She Z, Peng H et al (2024) Role of NLRP3 inflammasome in central nervous system diseases. Cell Biosci 14:75","journal-title":"Cell Biosci"},{"key":"4762_CR50","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096","journal-title":"Science"},{"key":"4762_CR51","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/s41419-020-03228-9","volume":"11","author":"CC Chiu","year":"2020","unstructured":"Chiu CC, Weng YH, Huang YZ, Chen RS, Liu YC, Yeh TH et al (2020) (D620N) VPS35 causes the impairment of Wnt\/\u03b2-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Cell Death Dis 11:1018","journal-title":"Cell Death Dis"},{"key":"4762_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-017-0154-3","volume":"12","author":"TE Moors","year":"2017","unstructured":"Moors TE, Hoozemans JJM, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC et al (2017) Therapeutic potential of autophagy-enhancing agents in Parkinson\u2019s disease. Mol Neurodegener 12:11","journal-title":"Mol Neurodegener"},{"key":"4762_CR53","first-page":"11","volume":"1771","author":"AB Pupyshev","year":"2019","unstructured":"Pupyshev AB, Tikhonova MA, Akopyan AA, Tenditnik MV, Dubrovina NI, Korolenko TA (2019) Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson\u2019s disease. Pharmacol Biochem Behav 1771:11","journal-title":"Pharmacol Biochem Behav"},{"key":"4762_CR54","doi-asserted-by":"publisher","first-page":"43277","DOI":"10.1074\/jbc.M107013200","volume":"276","author":"DS Castro","year":"2001","unstructured":"Castro DS, Hermanson E, Joseph B, Wall\u00e9n A, Aarnisalo P, Heller A et al (2001) Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J Biol Chem 276:43277\u201343284","journal-title":"J Biol Chem"},{"key":"4762_CR55","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s12035-021-02596-3","volume":"59","author":"IN Serratos","year":"2022","unstructured":"Serratos IN, Hern\u00e1ndez-P\u00e9rez E, Campos C, Aschner M, Santamar\u00eda A (2022) An update on the critical role of \u03b1-synuclein in Parkinson\u2019s disease and other synucleinopathies: from tissue to cellular and molecular levels. Mol Neurobiol 59:620\u2013642","journal-title":"Mol Neurobiol"},{"key":"4762_CR56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JPD-191790","volume":"10","author":"EP De Mattos","year":"2020","unstructured":"De Mattos EP, Wentink A, Nussbaum-Krammer C, Hansen C, Bergink S, Melki R et al (2020) Protein quality control pathways at the crossroad of synucleinopathies. J Parkinsons Dis 10:369","journal-title":"J Parkinsons Dis"},{"key":"4762_CR57","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","volume":"25","author":"RA Nixon","year":"2024","unstructured":"Nixon RA, Rubinszteinn DC (2024) Mechanisms of autophagy-lysosome dysfunction in neurodegenerative disease. Nat Rev Mol Cell Biol 25:926\u2013946","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4762_CR58","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1007\/s12035-023-03830-w","volume":"61","author":"Y Shen","year":"2024","unstructured":"Shen Y, Wang X, Nan N, Fu X, Zeng R, Yang Y et al (2024) SIRT3-mediated deacetylation of SDHA rescues mitochondrial bioenergetics contributing to neuroprotection in rotenone-induced PD models. Mol Neurobiol 61:4402\u20134420","journal-title":"Mol Neurobiol"},{"key":"4762_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuroscience.2024.10.033","volume":"562","author":"X Liang","year":"2024","unstructured":"Liang X, Wen Y, Feng C, Xu L, Xian Y, Xie H et al (2024) Neuroglobin protects dopaminergic neurons in a Parkinson\u2019s cell model by interacting with mitochondrial complex NDUFA10. Neuroscience 562:43\u201353","journal-title":"Neuroscience"},{"issue":"5","key":"4762_CR60","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11064-025-04569-7","volume":"50","author":"D Pensabene","year":"2025","unstructured":"Pensabene D, Martella N, Scavo G, Bisesto E, Cavicchia F, Colardo M et al (2025) p75NTR modulation by LM11A-31 counteracts oxidative stress and cholesterol dysmetabolism in a rotenone-induced cell model of Parkinson\u2019s disease. Neurochem Res 50(5):315","journal-title":"Neurochem Res"},{"issue":"12","key":"4762_CR61","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/aps.2016.75","volume":"37","author":"Z Mou","year":"2016","unstructured":"Mou Z, Yuan YH, Lou YX, Heng Y, Huang JY, Xia CY et al (2016) Bibenzyl compound 20c protects against endoplasmic reticulum stress in tunicamycin-treated PC12 cells in vitro. Acta Pharmacol Sin 37(12):1525\u20131533","journal-title":"Acta Pharmacol Sin"},{"key":"4762_CR62","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00418-008-0436-5","volume":"130","author":"R Boucher","year":"2008","unstructured":"Boucher R, Larkin H, Brodeur J, Gagnon H, Th\u00e9riault C, Lavoie C (2008) Intracellular trafficking of LRP9 is dependent on two acidic cluster\/dileucine motifs. Histochem Cell Biol 130:315\u2013327","journal-title":"Histochem Cell Biol"},{"key":"4762_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2017.04.004","volume":"154","author":"S Guhathakurta","year":"2017","unstructured":"Guhathakurta S, Bok E, Evangelista BA, Kim YS (2017) Deregulation of \u03b1-synuclein in Parkinson\u2019s disease: Insight from epigenetic structure and transcriptional regulation of SNCA. Progress Neurobiol 154:21\u201336","journal-title":"Progress Neurobiol"},{"key":"4762_CR64","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s12035-012-8301-x","volume":"46","author":"RJS Viana","year":"2012","unstructured":"Viana RJS, Nunes AF, Rodrigues CMP (2012) Endoplasmic reticulum enrollment in Alzheimer\u2019s disease. Mol Neurobiol 46:522\u2013534","journal-title":"Mol Neurobiol"},{"key":"4762_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","volume":"10","author":"M Vogler","year":"2025","unstructured":"Vogler M, Braun Y, Smith VM, Westhoff MA, Pereira RS, Pieper NM et al (2025) The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy. Signal Transduct Target Ther 10:91","journal-title":"Signal Transduct Target Ther"},{"key":"4762_CR66","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","volume":"12","author":"ICM Hoogland","year":"2015","unstructured":"Hoogland ICM, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D (2015) Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflamm 12:114","journal-title":"J Neuroinflamm"},{"key":"4762_CR67","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/ejn.16136","volume":"59","author":"M Regoni","year":"2024","unstructured":"Regoni M, Valtorta F, Sassone J (2024) Dopaminergic neuronal death via necroptosis in Parkinson\u2019s disease: A review of the literature. Eur J Neurosci 59:1079\u20131098","journal-title":"Eur J Neurosci"},{"key":"4762_CR68","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11064-025-04448-1","volume":"50","author":"A Kang","year":"2025","unstructured":"Kang A, Qiao Y, Pan S, Yan F, Chen H, Bai Y (2025) From RIPK1 to necroptosis: pathogenic mechanisms in neurodegenerative diseases. Neurochem Res 50:194","journal-title":"Neurochem Res"},{"key":"4762_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D (2019) Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci 20:19\u201333","journal-title":"Nat Rev Neurosci"},{"key":"4762_CR70","doi-asserted-by":"publisher","first-page":"701564","DOI":"10.3389\/fphar.2021.701564","volume":"12","author":"Z Yu","year":"2021","unstructured":"Yu Z, Jiang N, Su, Zhuo Y (2021) Necroptosis: A novel pathway in neuroinflammation. Front Pharmacol 12:701564","journal-title":"Front Pharmacol"},{"key":"4762_CR71","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1016\/j.febslet.2007.08.065","volume":"581","author":"K Choi","year":"2007","unstructured":"Choi K, Lee J, Choi C (2007) Divergent effect of proteasome inhibition on interleukin-1beta and tumor necrosis factor alpha signaling in human astroglial cells. FEBS Lett 581:4691\u20134696","journal-title":"FEBS Lett"},{"key":"4762_CR72","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/ijms20030649","volume":"20","author":"K Yasuda","year":"2019","unstructured":"Yasuda K, Nakanishi K, Tsutsui H (2019) Interleukin-18 in health and disease. Int J Mol Sci 20:649","journal-title":"Int J Mol Sci"},{"key":"4762_CR73","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1073\/pnas.181182298","volume":"98","author":"XG Xia","year":"2001","unstructured":"Xia XG, Harding T, Weller M, Bieneman A, Uney JB, Schulz JB (2001) Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 98:10433\u201310438","journal-title":"Proc Natl Acad Sci USA"},{"key":"4762_CR74","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/cdd.2012.42","volume":"19","author":"CY Chen","year":"2012","unstructured":"Chen CY, Weng YH, Chien KY, Lin KJ, Yeh TH, Cheng YP et al (2012) (G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD. Cell Death Differ 19:1623\u20131633","journal-title":"Cell Death Differ"},{"key":"4762_CR75","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.expneurol.2015.10.010","volume":"277","author":"Q Huang","year":"2016","unstructured":"Huang Q, Du X, He X, Yu Q, Hu K, Breitwieser W et al (2016) JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson\u2019s disease. Exp Neurol 277:296\u2013304","journal-title":"Exp Neurol"},{"key":"4762_CR76","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fnagi.2019.00316","volume":"11","author":"LY Wang","year":"2019","unstructured":"Wang LY, Yu X, Li XX, Zhao YN, Wang CY, Wang ZY et al (2019) Catalpol exerts a neuroprotective effect in the MPTP mouse model of Parkinson\u2019s disease. Front Aging Neurosci 11:316","journal-title":"Front Aging Neurosci"},{"key":"4762_CR77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/NRR.NRR-D-23-01195","volume":"20","author":"F Jiao","year":"2025","unstructured":"Jiao F, Meng L, Du K, Li X (2025) The autophagy-lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson\u2019s disease. Neural Regen Res 20:139\u2013158","journal-title":"Neural Regen Res"},{"key":"4762_CR78","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/cbf.3364","volume":"36","author":"DH Ho","year":"2018","unstructured":"Ho DH, Kim H, Nam D, Sim H, Kim J, Kim HG et al (2018) LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase. Cell Biochem Funct 36:431\u2013442","journal-title":"Cell Biochem Funct"},{"key":"4762_CR79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-016-0079-2","volume":"11","author":"E Duplan","year":"2016","unstructured":"Duplan E, Giordano C, Checler F, da Costa CA (2016) Direct \u03b1-synuclein promoter transactivation by the tumor suppressor p53. Mol Neurodegener 11:13","journal-title":"Mol Neurodegener"},{"key":"4762_CR80","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fnins.2018.00199","volume":"12","author":"DA Piper","year":"2018","unstructured":"Piper DA, Sastre D, Sch\u00fcle B (2018) Advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease. Front Neurosci 12:199","journal-title":"Front Neurosci"},{"key":"4762_CR81","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41418-019-0368-8","volume":"27","author":"T Valente","year":"2020","unstructured":"Valente T, Dentesano G, Ezquerra M, Fernandez-Santiago R, Martinez-Martin J, Gallastegui E (2020) CCAAT\/enhancer binding protein \u03b4 is a transcriptional repressor of \u03b1-synuclein. Cell Death Different 27:509\u2013524","journal-title":"Cell Death Different"},{"key":"4762_CR82","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1007\/s12035-024-03974-3","volume":"61","author":"I Schmitt","year":"2024","unstructured":"Schmitt I, Evert BO, Sharma A, Khazneh H, Murgatroyd C, W\u00fcllner U (2024) The alpha-synuclein gene (SNCA) is a genomic target of methyl-CpG binding protein 2 (MeCP2)-implications for Parkinson\u2019s disease and Rett syndrome. Mol Neurobiol 61:7830\u20137844","journal-title":"Mol Neurobiol"},{"key":"4762_CR83","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.omtn.2023.102084","volume":"35","author":"Z Sun","year":"2023","unstructured":"Sun Z, Kantor B, Chiba-Falek O (2023) Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies. Mol Ther Nucleic Acids 35:102084","journal-title":"Mol Ther Nucleic Acids"},{"key":"4762_CR84","doi-asserted-by":"publisher","first-page":"e2306682120","DOI":"10.1073\/pnas.2306682120","volume":"121","author":"Y Tong","year":"2024","unstructured":"Tong Y, Zhang P, Yang X, Liu X, Zhang J, Grudniewska M et al (2024) Decreasing the intrinsically disordered protein \u03b1-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera. Proc NatlbAcad Sci USA 121:e2306682120","journal-title":"Proc NatlbAcad Sci USA"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04762-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:04:46Z","timestamp":1782713086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04762-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4762"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04762-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"162"}}